Literature DB >> 24965291

Relationship between tumor necrosis factor-α release and granulocyte and monocyte adsorption to cellulose acetate beads.

Shoichi Nishise1, Yasuhiko Abe, Eiki Nomura, Takeshi Sato, Yu Sasaki, Daisuke Iwano, Kazuya Yoshizawa, Makoto Yagi, Yuko Nishise, Yoshiyuki Ueno.   

Abstract

Tumor necrosis factor-α, (TNF)-α, a proinflammatory cytokine, is produced by activated granulocytes and monocytes (GMs) and implicated as a major factor in inflammatory bowel disease (IBD) pathogenesis. Reduction of TNF-α should improve IBD pathology. GM adsorptive apheresis (GMA) is an effective therapy for inflammatory disorders including IBD. GM adsorption to cellulose acetate (CA) beads induces anti-inflammatory cytokine release, although these effects on TNF-α release are not clarified. We hypothesized that GMA may inhibit TNF-α release. The aim of the present study was to clarify the effects of GM adsorption to CA beads on TNF-α release in vitro. Peripheral blood was incubated with and without CA beads and TNF-α was measured. For comparison, TNF-α was measured in another lipopolysaccharide (LPS)-containing peripheral blood sample incubated similarly. The amount of TNF-α in blood samples incubated with CA beads was significantly higher than in those incubated without beads, although it was significantly lower than TNF-α incubated with LPS-containing sample without beads. The amount of TNF-α after incubation with CA beads positively correlated with GM adsorption ratio. GM adsorption to CA beads induced a small amount of TNF-α release. This is the first report on TNF-α release induced via GM adsorption stimuli. The biological effects of TNF-α release during GM adsorption need to be clarified.
© 2014 The Authors. Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis.

Entities:  

Keywords:  Adsorption; Apheresis; Granulocyte; Inflammatory bowel disease; Monocyte; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2014        PMID: 24965291     DOI: 10.1111/1744-9987.12212

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.

Authors:  Satoshi Tanida; Keiji Ozeki; Takuya Kanno; Takahito Katano; Naomi Sugimura; Hirotada Nishie; Hiroyasu Iwasaki; Mamoru Tanaka; Takaya Shimura; Eiji Kubota; Hiromi Kataoka
Journal:  J Clin Med Res       Date:  2021-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.